136 related articles for article (PubMed ID: 12880979)
1. Fenretinide as an anti-angiogenic agent in neuroblastoma.
Ribatti D; Raffaghello L; Marimpietri D; Cosimo E; Montaldo PG; Nico B; Vacca A; Ponzoni M
Cancer Lett; 2003 Jul; 197(1-2):181-4. PubMed ID: 12880979
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
Sogno I; Venè R; Sapienza C; Ferrari N; Tosetti F; Albini A
Recent Results Cancer Res; 2009; 181():71-6. PubMed ID: 19213559
[TBL] [Abstract][Full Text] [Related]
3. Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.
Sogno I; Venè R; Ferrari N; De Censi A; Imperatori A; Noonan DM; Tosetti F; Albini A
Crit Rev Oncol Hematol; 2010 Jul; 75(1):2-14. PubMed ID: 20034809
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenesis in neuroblastoma.
Ribatti D
Crit Rev Oncol Hematol; 2013 Jun; 86(3):212-21. PubMed ID: 23273512
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.
Pastorino F; Di Paolo D; Loi M; Becherini P; Caffa I; Zorzoli A; Marimpietri D; Carosio R; Perri P; Montaldo PG; Brignole C; Pagnan G; Ribatti D; Allen TM; Ponzoni M
Curr Drug Targets; 2009 Oct; 10(10):1021-7. PubMed ID: 19663770
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and anti-angiogenesis in neuroblastoma.
Ribatti D; Vacca A; Nico B; De Falco G; Giuseppe Montaldo P; Ponzoni M
Eur J Cancer; 2002 Apr; 38(6):750-7. PubMed ID: 11937307
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis as a target in neuroblastoma.
Rössler J; Taylor M; Geoerger B; Farace F; Lagodny J; Peschka-Süss R; Niemeyer CM; Vassal G
Eur J Cancer; 2008 Aug; 44(12):1645-56. PubMed ID: 18614349
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G
J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118
[TBL] [Abstract][Full Text] [Related]
10. Liposome-mediated therapy of neuroblastoma.
Di Paolo D; Loi M; Pastorino F; Brignole C; Marimpietri D; Becherini P; Caffa I; Zorzoli A; Longhi R; Gagliani C; Tacchetti C; Corti A; Allen TM; Ponzoni M; Pagnan G
Methods Enzymol; 2009; 465():225-49. PubMed ID: 19913170
[TBL] [Abstract][Full Text] [Related]
11. Interferon-mediated anti-angiogenic therapy for neuroblastoma.
Streck CJ; Ng CY; Zhang Y; Zhou J; Nathwani AC; Davidoff AM
Cancer Lett; 2005 Oct; 228(1-2):163-70. PubMed ID: 15927362
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
[TBL] [Abstract][Full Text] [Related]
14. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic strategies in neuroblastoma.
Ribatti D; Ponzoni M
Cancer Treat Rev; 2005 Feb; 31(1):27-34. PubMed ID: 15707702
[TBL] [Abstract][Full Text] [Related]
16. Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents.
Lovat PE; Ranalli M; Bernassola F; Tilby M; Malcolm AJ; Pearson AD; Piacentini M; Melino G; Redfern CP
Med Pediatr Oncol; 2000 Dec; 35(6):663-8. PubMed ID: 11107142
[TBL] [Abstract][Full Text] [Related]
17. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
18. Rationale, problems and perspectives in anti-angiogenic therapy.
Lorusso G; Dell'Eva R; Vené R; Pfeffer U; Albini A
Tumori; 2001; 87(6):S17-9. PubMed ID: 11989611
[No Abstract] [Full Text] [Related]
19. Inhibitory effect of TNP-470 on hepatic metastasis of mouse neuroblastoma.
Yoshizawa J; Mizuno R; Yoshida T; Hara A; Ashizuka S; Kanai M; Kuwashima N; Kurobe M; Yamazaki Y
J Surg Res; 2000 Sep; 93(1):82-7. PubMed ID: 10945947
[TBL] [Abstract][Full Text] [Related]
20. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.
Kim ES; Serur A; Huang J; Manley CA; McCrudden KW; Frischer JS; Soffer SZ; Ring L; New T; Zabski S; Rudge JS; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11399-404. PubMed ID: 12177446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
